Posts

Showing posts with the label Clostridium Difficile Infection Treatment

Clostridium Difficile Infection Treatment Market is expected to reach USD 1252.8 Million by 2025 with a CAGR of 5.38% over the forecast period

Image
    Clostridium difficile, which produces gram-positive bacterium, can be an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection could be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic acid amplification tests for Clostridium difficile toxin genes or endoscopy. Clostridium difficile infection occurs during antibiotic treatment or could be caused as a result of healthcare associated infection with clinical manifestation including asymptomatic infection to watery diarrhea or serious intestinal condition such as for example like colitis and colonic perforation. Clostridium Difficile Infection Treatment Market was forecast to be US$ 840 Mn in 2018, and expected to attain USD 1252.8 Million by 2025 with a CAGR of 5.38% within the forecast period. The report presents a great account of the global clostridium difficile infection treatment market, concentrat...

Popular posts from this blog

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Crude Tall Oil Market is Anticipated to Witness High Growth Owing to Rising Demand from Construction Industry

Helicobacter Pylori Diagnostics Market share, Size, trends and industry Analysis